-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VnXWG/8rxe6CzbVrIm11u6UzxPs0AlxKt5ARHBmGsWw8oIK1pHrqpQFvtGXK1qg0 kNmuKJ0pIGcE4CZUcHNMZQ== 0001209191-06-062204.txt : 20061201 0001209191-06-062204.hdr.sgml : 20061201 20061201092005 ACCESSION NUMBER: 0001209191-06-062204 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20061129 FILED AS OF DATE: 20061201 DATE AS OF CHANGE: 20061201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MARTIN STEPHEN CENTRAL INDEX KEY: 0001234364 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24274 FILM NUMBER: 061249678 BUSINESS ADDRESS: STREET 1: C/O LA JOLLA PHARMACEUTICAL CO STREET 2: 6455 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8586466649 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6455 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584526600 MAIL ADDRESS: STREET 1: 6455 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2006-11-29 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001234364 MARTIN STEPHEN 6455 NANCY RIDGE DRIVE SAN DIEGO CA 92121 1 0 0 0 Stock Option (right to buy) 3.25 2006-11-29 4 A 0 2000 0.00 A 2016-11-29 Common Stock 2000 2000 D The stock options vest and become exercisable with respect to 50% of the underlying shares on 11/29/2006 and with respect to the remaining 50% of the underlying shares on 11/29/2007. /s/ Gail A. Sloan Attorney-in-fact for Stephen M. Martin 2006-12-01 EX-24.4_161076 2 poa.txt POA DOCUMENT POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Deirdre Y. Gillespie, M.D. and Gail A. Sloan signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer, director or ten percent stockholder of La Jolla Pharmaceutical Company (the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Act of 1934, as amended. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of April 28, 2006. Signature: /s/ Stephen M. Martin Print Name: Stephen M. Martin -----END PRIVACY-ENHANCED MESSAGE-----